Comparing Selective Serotonin Reuptake Inhibitors (SSRIs) Alone and in Combination With Beta-Blockers for Treating Panic Disorders: A Prospective Cohort Study.

Background Panic disorders are prevalent psychiatric conditions affecting 1.6% to 2.2% of the global population.